Literature DB >> 7550291

Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary.

T M Böckers1, M R Kreutz, T Pohl.   

Abstract

The expression of the glutaminyl cyclase (QC), an enzyme responsible for the post-translational modification of N-terminal pyroglutamyl residues of neuropeptide precursors, was examined in bovine/porcine hypothalamic and pituitary tissue by means of immunocytochemistry and in situ hybridization. In the anterior pituitary a distinct pattern of QC immunoreactivity and mRNA expression was found associated exclusively with somatotrophs. In corticotrophs of the pars intermedia QC expression was undetectable, whereas a small portion of putative pars tuberalis cells in the rostral part of the pars distalis were heavily labelled. The neurointermediate lobe was devoid of signals for QC mRNA, but showed significant QC-immunoreactivity on secretory granules of axonal nerve endings. Also nuclei of the hypothalamus were found to be positive for QC-immunoreactivity. Intense labelling was observed in the nucleus supraopticus and nucleus paraventricularis. Staining of the nucleus periventricularis was found to be moderate, whereas no labelling of perikarya in the nucleus arcuatus, the preoptic area and the nucleus suprachiasmaticus was detectable. Moreover, varicose fibers stained positive for QC-immunoreactivity and could be identified in the main transport route from the hypothalamus to the pars neuronalis (tractus hypothalamo hypophysialis). These results suggest that the enzyme is transported via the same routes as its substrate/product to the median eminence or the neural lobe. Furthermore, the mapping of the cellular QC distribution reveals a strikingly distinctive expression pattern, that should be useful for the identification of yet undiscovered places of peptide synthesis and processing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550291     DOI: 10.1111/j.1365-2826.1995.tb00780.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  13 in total

1.  Oxidative folding and N-terminal cyclization of onconase.

Authors:  Ervin Welker; Laura Hathaway; Guoqiang Xu; Mahesh Narayan; Lovy Pradeep; Hang-Cheol Shin; Harold A Scheraga
Journal:  Biochemistry       Date:  2007-04-18       Impact factor: 3.162

2.  Crystallization and preliminary X-ray diffraction studies of the glutaminyl cyclase from Carica papaya latex.

Authors:  Mohamed Azarkan; Bernard Clantin; Coralie Bompard; Hassan Belrhali; Danielle Baeyens-Volant; Yvan Looze; Vincent Villeret; René Wintjens
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-10-23

3.  Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development.

Authors:  Stephan Schilling; Stephanie Kohlmann; Christoph Bäuscher; Reinhard Sedlmeier; Birgit Koch; Rico Eichentopf; Andreas Becker; Holger Cynis; Torsten Hoffmann; Sabine Berg; Ernst-Joachim Freyse; Stephan von Hörsten; Steffen Rossner; Sigrid Graubner; Hans-Ulrich Demuth
Journal:  J Biol Chem       Date:  2011-02-17       Impact factor: 5.157

4.  Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms.

Authors:  Maike Hartlage-Rübsamen; Markus Morawski; Alexander Waniek; Carsten Jäger; Ulrike Zeitschel; Birgit Koch; Holger Cynis; Stephan Schilling; Reinhard Schliebs; Hans-Ulrich Demuth; Steffen Rossner
Journal:  Acta Neuropathol       Date:  2011-02-08       Impact factor: 17.088

5.  The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions.

Authors:  Holger Cynis; Torsten Hoffmann; Daniel Friedrich; Astrid Kehlen; Kathrin Gans; Martin Kleinschmidt; Jens-Ulrich Rahfeld; Raik Wolf; Michael Wermann; Anett Stephan; Monique Haegele; Reinhard Sedlmeier; Sigrid Graubner; Wolfgang Jagla; Anke Müller; Rico Eichentopf; Ulrich Heiser; Franziska Seifert; Paul H A Quax; Margreet R de Vries; Isabel Hesse; Daniela Trautwein; Ulrich Wollert; Sabine Berg; Ernst-Joachim Freyse; Stephan Schilling; Hans-Ulrich Demuth
Journal:  EMBO Mol Med       Date:  2011-07-20       Impact factor: 12.137

6.  Human glutaminyl cyclase and bacterial zinc aminopeptidase share a common fold and active site.

Authors:  Rachell E Booth; Simon C Lovell; Stephanie A Misquitta; Robert C Bateman
Journal:  BMC Biol       Date:  2004-02-10       Impact factor: 7.431

7.  Natural Products from Microalgae with Potential against Alzheimer's Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors.

Authors:  Stephanie Hielscher-Michael; Carola Griehl; Mirko Buchholz; Hans-Ulrich Demuth; Norbert Arnold; Ludger A Wessjohann
Journal:  Mar Drugs       Date:  2016-11-02       Impact factor: 5.118

8.  Identification of Glutaminyl Cyclase Genes Involved in Pyroglutamate Modification of Fungal Lignocellulolytic Enzymes.

Authors:  Vincent W Wu; Craig M Dana; Anthony T Iavarone; Douglas S Clark; N Louise Glass
Journal:  MBio       Date:  2017-01-17       Impact factor: 7.867

9.  Neuropeptidomics of the supraoptic rat nucleus.

Authors:  Adriana Bora; Suresh P Annangudi; Larry J Millet; Stanislav S Rubakhin; Andrew J Forbes; Neil L Kelleher; Martha U Gillette; Jonathan V Sweedler
Journal:  J Proteome Res       Date:  2008-09-25       Impact factor: 4.466

10.  Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo.

Authors:  Yan-Ping Shih; Chi-Chi Chou; Yi-Ling Chen; Kai-Fa Huang; Andrew H-J Wang
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.